Biotechnology and Government Funding

Michael Lawlor

Challenge, 2003, vol. 46, issue 1, pages 15-37

Abstract: Why is the United States the leader in biotechnology? The author argues it is because it has adopted a public-goods model actively involving government spending and decision-making. The private market alone will not support adequate basic research. But does the government support its research well? The author argues that it is not perfect, but it has been highly successful.

Date: 2003

Downloads: (external link)
http://mesharpe.metapress.com/link.asp?target=contribution&id=7RV4D5FNGA9GTEJ4 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:mes:challe:v:46:y:2003:i:1:p:15-37

Access Statistics for this article

More articles in Challenge from M.E. Sharpe, Inc.
Series data maintained by Christopher F. Baum ().